Akebia TherapeuticsAKBA 
$1.871.63%24h
1.63%24h
Global rank2955
Market cap$352.29M
Change 7d-4.10%
YTD Performance53.28%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Akebia Therapeutics (AKBA)
As of December 2024, Akebia Therapeutics has a market cap of $352.29M. This makes Akebia Therapeutics the world's 2955th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Akebia Therapeutics from 2014 to 2024
-
Value:-
Market cap history of Akebia Therapeutics from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $276.95M | 18.56% |
| 2023 | $233.60M | 114.90% |
| 2022 | $108.70M | -74.47% |
| 2021 | $425.76M | -19.29% |
| 2020 | $527.49M | -55.70% |
| 2019 | $1.19B | 14.29% |
| 2018 | $1.04B | -62.81% |
| 2017 | $2.80B | 42.84% |
| 2016 | $1.96B | -19.43% |
| 2015 | $2.43B | 11.00% |
| 2014 | $2.19B | - |
AKBA Market Cap Today is $352.29M 1.63% - 18 Dec 2024
View largest stocks by market cap 
